1 Aims and Scope
The CGE Journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention research papers describing original researches and reviews of broad general interest in Cancer - a particular emphasis is placed on Molecular Genetics and Epigenetics.
The journal encourages and publishes articles that report novel findings of wide biological significance in the areas of:
Computational Cancer Genomics
Molecular Network in Cancer
Hormones and cancer
Cancer Genomics and targets
Expression patterns in Cancer cells and tumors
Molecular and cellular pathobiology
Tumor and stem cell biology
Prevention and epidemiology
The CGE Journal has a fair and transparent process to rapidly publish important science.
The authors permanently reserve the copyright for their publications and have granted the rights to any third party in advance for using, reproducing or disseminating the work under the terms of copyright and license of the BioPublisher’s constitutions and adopted law and regulations.
3 Manuscripts Submission
3.1 Online submission
Manuscripts must be submitted to Cancer Genetics and Epigenetics (CGE) electronically by BioPublisher's online submission system. In cases that online submission system is not available, you can submit your manuscript to the submission email of Cancer Genetics and Epigenetics (CGE): firstname.lastname@example.org. If both of the above ways do not work out, you can directly send your manuscripts to the Publishing Manager by email@example.com. The editors will handle your submission within five working days.
Preferred file formats of manuscripts are Microsoft Word and Rich Text Format (RTF). Figures, tables, movies, and raw data can be submitted as supplementally files.
A cover letter must be submitted along with the manuscript during the submission, which should contain a brief explanation of what was previously known, the conceptual advance provided by the findings, and the importance of the findings to a broad readership, as well as how and why their major findings relate to the scope of the journal. Closely related papers submitted elsewhere or in press should be noted in the cover letter and uploaded as additional supplementally files in the online submission system. The cover letter is confidential to the editor and will not be seen by reviewers.
3.2 Corresponding Author
The full name, the contact information, and e-mail address of the corresponding author should be provided. We take the corresponding author as the responsible author, which means that the corresponding author accepts such a responsibility: The corresponding author must warrant that all co-authors have read and approved the authorship of the manuscript, the content of the paper, and its submission to CGE. Official approval of all original authors must be provided before any changes in authorship. All reasonable demands on the necessary materials and methods which can justify the experimental results must be satisfied. Please inform the editorial office if the contact information of the corresponding author changes after submission.
4 Article processing
Scientists all over the world are invited to be as peer reviewers for this journal. All submission will be automatically transferred online to the reviewers by Manuscript Proceeding System in the BioPublisher prior to CrossRef’s plagiarism check. (see BioPublisher peer review policy for further information)
Cancer Genetics and Epigenetics (CGE) offers a fast publication schedule whilst maintaining rigorous peer review. Normally the publication period is two or four weeks depend on the speed of peer review. Using the recommended manuscript preparation formats will largely speed up the paper procedures and shorten the periods. Research articles will be published electronically in provisional PDF immediately upon acceptance. A fully structured web version and PDF download version will be uploaded within four weeks after acceptance.
Cancer Genetics and Epigenetics (CGE) is affiliated with other biology journals published by BioPublisher, including Genomics and Applied Biology and other journals. If referees judge that a manuscript is sound but not of special interest and therefore not appropriate for Cancer Genetics and Epigenetics (CGE), the referee reports can be shared with other journals published by BioPublisher. Transferring a manuscript from one journal to another will not incur delays. Conversely, if a manuscript submitted to a sister journal in the BioPublisher series is judged to be of exceptional interest by the referees and editors. We may offer publication in Cancer Genetics and Epigenetics (CGE).
5 Article-processing charges
Cancer Genetics and Epigenetics (CGE) levies an article-processing charge for every accepted article to cover the costs incurred by open access publication. Article-processing charge for all BioPublisher journals is in uniform. BioPublisher’s standard article-processing charge is Canadian dollar 1200 CAD (US dollar $1200), which has no any tax fee included. For authors from the Canada, their article processing charges levied by BioPublisher contain 12% of HST tax fee, and this tax fee will be listed solely upon invoice. For authors other than from the Canada, their article processing charges are exclusive of any tax fees. Authors from low-income countries and areas or having financial difficulties can apply the discount for APC upon submission and if the authors are qualified to be waived they don’t necessarily pay the APC. For further information please see Charge FAQ.
Payment for APC in this Journal should be made to Sophia Publishing Group Inc. Payment procedure will be informed upon submission acceptance.